Influence of sex as an intrinsic biological variable in a primary cell model of HIV latency

Influence of sex as an intrinsic biological variable in a primary cell model of HIV latency

Bibliographic Details
Main Authors:	A.B. Macedo, L.J. Martins, A.M. Spivak, M.A. Szaniawski, V. Planelles, A. Bosque
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020305975

Similar Items

Diverse interferons restrict HIV-1 Infection in macrophages through activation of SAMHD1
by: M. Szaniawski, et al.
Published: (2017-12-01)

CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent
by: A. Macedo, et al.
Published: (2015-12-01)

Ingenol derivatives are potent reactivators of latent HIV
by: V. Planelles, et al.
Published: (2015-12-01)

Epigenetic regulation of HIV-1 latency by cytosine methylation.
by: Steven E Kauder, et al.
Published: (2009-06-01)

Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5
by: A. Bosque, et al.
Published: (2015-12-01)

Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIV
by: Tinus Schynkel, et al.
Published: (2020-10-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019-12-01)

Shining the RNA-Seq microscope on models of HIV latency
by: C.H. Woelk, et al.
Published: (2015-12-01)

Tyrosine kinase inhibition: the new front in HIV cure efforts
by: V. Planelles, et al.
Published: (2019-12-01)

In-depth transcription profile comparison of multiple primary cell HIV latency models
by: S. Moron-Lopez, et al.
Published: (2019-07-01)

HUSH, a Link Between Intrinsic Immunity and HIV Latency
by: Ghina Chougui, et al.
Published: (2019-02-01)

Cleavage and polyadenylation specific factor 6 is required for HIV latency reversal
by: Y. Zheng, et al.
Published: (2019-12-01)

Single cell analysis reveals molecular signatures of HIV latency in primary cell models
by: S. Telwatte, et al.
Published: (2019-12-01)

Utilising genetic barcodes to understand the role of silent integration in HIV latency
by: E. Larragoite, et al.
Published: (2019-12-01)

Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV
by: A.B. Macedo, et al.
Published: (2017-12-01)

CD4+ T cells expressing CD32 from HIV-1-positive patients are not enriched for proviral DNA
by: A.M. Spivak, et al.
Published: (2017-12-01)

Intrinsic Timing Jitter and Latency in Superconducting Nanowire Single-photon Detectors
by: Allmaras, J.P, et al.
Published: (2019)

HIV Latency Reversing Agents have diverse effects on Natural Killer Cell Function
by: Carolina Garrido, et al.
Published: (2016-09-01)

Role of mitochondrial antiviral signaling protein in reactivation of latent HIV-1 in CD4+ T cells
by: C.L. Novis, et al.
Published: (2017-12-01)

Interactions with pathogenic bacteria induce HIV-1 latency in macrophages through altered transcription factor recruitment to the LTR
by: T. Hanley, et al.
Published: (2019-12-01)

SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition
by: Matthew A. Szaniawski, et al.
Published: (2018-05-01)

Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal.
by: Wim Trypsteen, et al.
Published: (2019-01-01)

Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.
by: Cory H White, et al.
Published: (2016-11-01)

Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation
by: Alberto Bosque, et al.
Published: (2017-01-01)

Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency.
by: Stephen A Rawlings, et al.
Published: (2015-01-01)

Epigenomic characterisation of a primary cell model of HIV latency
by: E. Browne, et al.
Published: (2019-12-01)

An unbiased platform to identify regulators of HIV latency in infected primary human CD4 T Cells
by: U. Rathore, et al.
Published: (2019-12-01)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017-12-01)

Visualisation of HIV reactivation from latency in primary resting memory T-cells
by: F. Kizito, et al.
Published: (2019-12-01)

Stability of HTLV/HIV dual infection model with mitosis and latency
by: A. M. Elaiw, et al.
Published: (2021-04-01)

Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency
by: Daniela A. Covino, et al.
Published: (2021-06-01)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016-07-01)

Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.
by: Pejman Mohammadi, et al.
Published: (2014-05-01)

Cellular and molecular mechanisms involved in the establishment of HIV-1 latency
by: Donahue Daniel A, et al.
Published: (2013-02-01)

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019-07-01)

A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
by: Kara G Lassen, et al.
Published: (2012-01-01)

Targeted screens identify new chromatin regulators of HIV latency
by: A.-M. Turner, et al.
Published: (2017-12-01)

On the Intrinsic Simplicity of Spectral Variability of GRBs
by: A. Chernenko
Published: (2011-01-01)

Bioactive Compounds from <i>Euphorbia usambarica</i> Pax. with HIV-1 Latency Reversal Activity
by: Yu-Chi Tsai, et al.
Published: (2021-07-01)

The steroid receptor coactivators are targets for reactivation of HIV latency
by: B.C. Nikolai, et al.
Published: (2015-12-01)